Word

BOBCAT

Status

Pending

Status Code

641

Status Date

Wednesday, May 29, 2024

Serial Number

98207353

Mark Type

4

Filing Date

Tuesday, October 3, 2023

Trademark Owner History

Elixirgen Therapeutics, Inc.

Classifications

5 RNA dosage medium preparations carrying genes encoding proteins for treating or preventing genetic diseases; RNA dosage medium preparations carrying genes encoding proteins for treating or preventing infectious diseases; RNA dosage medium preparations carrying genes encoding proteins for treating or preventing cancers; RNA dosage medium preparations carrying genes encoding proteins for treating or preventing age-related diseases; RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for gene editing; RNA dosage medium preparations carrying genes encoding ribonucleoprotein constructs for treating telomere shortening; RNA dosage medium preparations carrying genes encoding proteins for regenerative medicine

42 Development of pharmaceutical products for others; product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; pharmaceutical products development; product quality evaluation; product quality testing; product quality testing services; pharmaceutical research services; pharmaceutical research and development; product research and development; research and development of new products; research and development in the pharmaceutical and biotechnology fields; research and development in the field of medical products

Trademark Events

Oct 6, 2023

New Application Entered

Oct 12, 2023

New Application Office Supplied Data Entered

May 23, 2024

Assigned To Examiner

May 29, 2024

Non-Final Action E-Mailed

May 29, 2024

Non-Final Action Written

May 29, 2024

Notification Of Non-Final Action E-Mailed